Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) today announced the launch of Amikacin Sulfate Injection, USP, an anti-infective/antibiotic, in 500 mg ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE